Results 101 to 110 of about 228,987 (365)

Characterization of the complete chloroplast genome of Allium prattii

open access: yesMitochondrial DNA. Part B. Resources, 2018
The genus Allium is one of the world’s largest monocot genera. However, few reports on the complete chloroplast genome of Allium plants are reported. In this study, we reported the complete chloroplast genome of Allium prattii.
Fang-Yu Jin   +3 more
doaj   +1 more source

The complete chloroplast genome sequence of Knema elegans (Myristicaceae)

open access: yesMitochondrial DNA. Part B. Resources, 2020
Knema elegans is a member of Myristicaceae. The K. elegans chloroplast genome is found to be 155,691 bp in length and has a base composition of A (30.02%), G (19.31%), C (19.89%), and T (30.78%).
Chang-Li Mao   +5 more
doaj   +1 more source

The complete chloroplast genome of Cotyledon tomentosa Harv.

open access: yesMitochondrial DNA. Part B. Resources, 2021
Cotyledon tomentosa Harv. is a well-known succulent plant that have important ornamental and economic value. In this study, we release and detail the complete chloroplast genome sequences of C. tomentosa.
Yanfeng He   +6 more
doaj   +1 more source

Mammalian Tolerance to Amino Acid Heterochirality

open access: yesChemBioChem, Accepted Article.
Organisms use amino acids predominantly in l‐configuration. On the other hand, a series of studies show that a variety of d‐amino acids also occur in mammals and amino acid homochirality is not complete. Mammals de novo synthesize most amino acids with l‐configuration, but serine and aspartate are converted from l‐ to d‐configuration by endogenous ...
Jumpei Sasabe   +4 more
wiley   +1 more source

The complete chloroplast genome sequence of Knema furfuracea (Myristicaceae)

open access: yesMitochondrial DNA. Part B. Resources, 2020
Knema furfuracea is a member of Myristicaceae. The K. furfuracea chloroplast genome is found to be 154,527 bp in length and has a base composition of A (29.99%), G (19.31%), C (19.92%), and T (30.78%).
Tian Yang   +5 more
doaj   +1 more source

The complete chloroplast genome of Hippeastrum rutilum (Ker-Gawl.) Herb.

open access: yesMitochondrial DNA. Part B. Resources, 2021
Hippeastrum rutilum (Ker-Gawl.) Herb. is a high-end ornamental flower in the family Amaryllidaceae. In this study, the complete chloroplast genome sequence of H. rutilum (Ker-Gawl.) Herb. was determined from Illumina pair-end sequencing data.
Li He   +4 more
doaj   +1 more source

GDC 2: Compression of large collections of genomes [PDF]

open access: yesScientific Reports, Article no. 11565 (2015), 2015
The fall of prices of the high-throughput genome sequencing changes the landscape of modern genomics. A number of large scale projects aimed at sequencing many human genomes are in progress. Genome sequencing also becomes an important aid in the personalized medicine.
arxiv   +1 more source

The complete chloroplast genome of Hemerocallis Fulva [PDF]

open access: yesMitochondrial DNA Part B, 2019
We have sequenced the complete chloroplast genome of Hemerocallis fulva, a species of the Asphodelaceae family, through Illumina HiSeq paired-end sequencing. The total size of chloroplast genome of Hemerocallis fulva was 155,855 bp with a large single-copy (LSC) region of 84,607 bp, a small single-copy (SSC) region of 18,508 bp, and a pair of identical
So Yeon Kim   +5 more
openaire   +4 more sources

Mitochondrial Molecular Adaptations and Life History Strategies Coevolve in Plants [PDF]

open access: yes, 2008
Messenger RNA secondary structure prevents mutations at functionally important sites. Mutations at exposed sites would cause micro-adaptations, niche-specialization, and therefore, can be thought to promote K-strategists. Exposing, rather than protecting,
Basuthkar J. Rao, Neeraja M. Krishnan
core   +2 more sources

Exploring the Potential and Advancements of Circular RNA Therapeutics

open access: yesExploration, EarlyView.
Given the remarkable advantages in terms of stability, sustained expression profile, safety, wide range of druggable targets, scalable and cost‐effective manufacturing capabilities, circRNA is currently undergoing intensive investigation for various therapeutic applications such as vaccines, protein replacement, genetic disease treatment, gene therapy,
Lei Wang   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy